Immunoglobulins drive terminal maturation of splenic dendritic cells
The molecular mechanisms of cross-presentation remain still largely elusive and multiple pathways of antigen transport, processing, and loading might exist, which are not mutually exclusive.
Ovalbumin (OVA) is one of the best studied model antigens in cross-presentation.
Soluble OVA has been proposed to be engulfed via mannose receptor (MR) mediated endocytosis into specialized stable early endosomal compartments.
Subsequently, antigen is exported to the cytosol, processed by proteasomal degradation and re-imported via TAP to early endosomes for final trimming by the insulin-regulated aminopeptidase IRAP and loaded onto MHC I molecules [3, [5] [6] [7] .
However, different forms of antigen may be cross-presented via different routes [4] .
Homeostasis and function of the immune system requires complex interactions between its components. Accordingly, T and B cells influence development, function and maturation status of DC. In addition to well-established role of T cells in shaping DC function [8] [9] [10] B cells appear to be able to modulate the functional maturation of DC [11] . Thus, lack of B cells skews the T cell response towards Th1 by promoting expression of IL-12 by DC. Such regulatory function is likely to be mediated via secretion of cytokines [11] . Immunoglobulins (Ig) constitute the largest fraction of secretory molecules from B cells. They, mostly in the form of immune complexes (IC) or acting via Fc receptors, have been suggested to influence DC function and, in particular, cross-presentation [12, 13] . However, the mechanism and extent how Ig and/or IC affect DC maturation and antigen presentation remain poorly understood.
Therefore, we tested the hypothesis that development of fully functional DC depends on the presence of a functional adaptive immune system. We observed that crosspresentation of soluble antigen by splenic conventional DC (cDC) generated in lymphopenic mice was severely impaired. This inefficient cross-presentation in the absence of T and B cells was due to aberrant antigen trafficking and rapid degradation of antigen, thus preventing efficient loading and antigen presentation by MHC I. We showed that efficient cross-presentation depended on serum Ig, which presumably acts via C-type lectin receptors (CLR). Taken together, our results reveal a novel mechanism for regulation of DC development via soluble Ig.
Results
Impaired cross-presentation by splenic cDC generated in a lymphopenic environment. Function of DC critically depends on their maturation status.
Therefore, first we re-assessed how lack of components of the adaptive immune system affects maturation of splenic DC to full function. To this end, we examined splenic conventional DC (cDC) from RAG-deficient mice that lack T and B cells and WT mice for their maturation status and capacity to present antigen. No major differences in surface expression of MHC I, MHC II, CD1d, ICAM-1 and other costimulatory molecules were observed (Fig. 1A) , indicating an overall similar maturation status of splenic cDC from RAG -/-and WT mice. Next, we sensitized cDC from either mouse strain with soluble ovalbumin (OVA), which requires crosspresentation, or with cognate peptide (SIINFEKL, OVA 257-264 ), which is independent of cross-presentation. OVA protein-sensitized splenic cDC isolated from RAGdeficient mice were impaired in priming OT I T cells compared to OVA-loaded WT cDC (Fig. 1B) . In contrast, peptide-pulsed cDC from RAG-deficient and WT mice primed OT I T cells equally well. Thus, while displaying a comparable maturation status at the cell surface, splenic cDC from RAG-deficient mice cannot cross-present soluble antigen effectively.
Absence of T and B cells during cDC development in vivo leads to different
antigen trafficking and enhanced degradation. We set out to identify the mechanism underlying the deficiency in cross-presentation by cDC from RAG -/-mice.
First, we performed gene expression analysis using sorted splenic CD8α and WT mice. This revealed that amongst others several C-type lectin receptors (CLR) were expressed at elevated levels in cDCs from lymphopenic mice as were genes encoding endolysosomal enzymes including Cathepsins ( Fig. 2A ). Since Cathepsins require proteolytic processing for activation, the analysis of mRNA expression and immunofluorescent microscopy ( Fig. S1 ) are only of limited value. Western blot analysis revealed that in splenic cDC from RAG-deficient mice Cathepsins D, E and B are indeed present at highly elevated levels in catalytically active form when compared to cDC from WT mice (Fig. 2B) . Thus, more efficient antigen uptake and more aggressive degradation of soluble antigen could be a possible consequence. Indeed, analysis of antigen uptake using fluorophore-coupled OVA (OVA-Cy5) demonstrated increased endocytosis of OVA by cDCs from RAG -/-mice ( Fig. 2C) . Similarly, as predicted, antigen processing was increased in RAG We conclude that in splenic cDC from lymphopenic mice antigen is miss-targeted to late endosomal/lysosomal compartments resulting in enhanced degradation of antigen and, consequently, in inefficient cross-presentation.
Soluble immunoglobulin is sufficient to restore efficient cross-presentation by cDC from lymphopenic mice. We next wanted to delineate the critical factors required for proper maturation of splenic cDC that are lacking in RAG-deficient mice. essentially confirmed our mRNA expression data (Fig. 4B) . We also included the CLR Clec9a in our analysis, since it had been shown to bind dead-cell associated antigens and regulate cross-presentation [14, 15] . Whereas in WT mice a large fraction of CD8 + DC was virtually Clec9a-negative, this population of Clec9a-negative CD8 + DC was almost absent from RAG-deficient mice (Fig. 4B) (Fig. 4C) . These results are in line with our finding that not only IgG, but also IgM, can restore cross-presentation. Consistent with previous reports [12, 13] , cDC isolated from FcRγ -/-and FcγRI/II/III -/-mice were impaired in crosspresenting OVA-IC (Fig. 4D) . Alternatively, IC associated with components of the complement system could engage complement receptors present on splenic cDC [16, 17] . The component C3 is essential for the activation of the complement system and is required for all three pathways -the classical, the alternative, and the lectin pathway. Therefore, we analyzed cross-presentation of cDC from complement component 3 (C3) deficient mice. However, splenic cDC from such mice were as efficient as WT cDC in cross-presentation of OVA, thus, excluding IC and engagement of complement receptors as modulators of cross-presentation (Fig. 4E ).
Of note, presentation of other than soluble Ag, like cell associated OVA, was not affected in cDC from RAG -/-mice (Fig. 4F) . Taken together, these data indicate that Ig affects DC function at at least two distinct levels: IC-FcR interaction and, more fundamentally, FcR-independent in a non-complexed form. The dichotomy of Igdependent and Ig-independent cross-presentation of soluble antigen and apoptotic cells, respectively, is consistent with the assumption that humoral immunity has a greater role in clearance of soluble antigen than in removal of infected cells.
CLR, like DC-SIGN or SIGN-R1, constitute a large group of surface receptors, more than 20 of which can be expressed on myeloid cells [18] . Such receptors have been shown to engage Ig via their carbohydrates and potentially interfere with immune reactions [19] . Hence, they could be involved in the functional maturation of splenic DC. Mannan derived from S. cerevisiae is widely considered to be a specific inhibitor of CLR [20] . Thus, we administered mannan to RAG -/-or WT mice prior to administration of IgG and tested the influence on the recovery of cross-presentation capacity by cDC. Importantly, administration of mannan alone did not induce maturation of DC as assessed by surface staining for MHC I, CD40 as well as the co-stimulatory ligands CD80 and CD86 (Fig. S3) . Interestingly, in the presence of mannan, IgG could not restore cross-presentation in cDC from RAG -/-mice (Fig. 4G) .
Mannan treatment reduced cross-presentation to some extent in cDC from WT mice, since uptake of soluble OVA depends on MR [6] . In order to closer investigate the receptor candidates, we tested bone marrow derived DC (BMDC) from MR-deficient mice. However, in the absence of MR binding of Ig was not impaired when compared to WT BMDC (Fig. S4 ). This indicates that MR alone is not responsible for functional pathogens that do not directly infect DC [22, 23] . Therefore DC, the main APC that possess the ability to cross-present, play a crucial role in maintaining the subtle balance between tolerance and autoimmunity as well as protective T cell responses.
Factors that influence this balance might be very important targets for therapeutic interventions.
In our studies, we used the lymphopenic mouse model where a deficiency in the Our experiments showed that transfer of naïve T cells into RAG-deficient mice only mildly enhanced the cross-presenting abilities of splenic cDC. This finding does not correlate with a previous report by Shreedhar et al., [25] in which the authors showed that adoptive transfer of immune T cells can restore the disturbed antigen presentation capacity of DC from lymphopenic mice. However, the two systems are difficult to compare. Immune T cells were essential in the in vivo assays and hapten was used as antigen for skin sensitization. Thus, most likely skin derived Langerhans cells from lymphopenic mice were targeted. Such DC are known to follow a different developmental pathway compared to normal cDC [26] . In our case, the DC from lymphopenic hosts showed properties of their monocytic precursor. For instance, they still expressed CD14 and exhibited a high capacity for lysosomal degradation.
The signal elicited by circulating Ig was presumably required for a full differentiation after acquisition of residency in the spleen.
Differential expression of CLR and endolysosomal enzymes in splenic cDC that had developed in a lymphopenic environment suggested that such cDC might exhibit altered antigen uptake and target soluble antigens into degradation pathways different from WT DC. Indeed, we could show that cDC isolated from RAG-deficient mice have a slightly higher ability to acquire soluble antigen in comparison to WT cDC. However, cDC from lymphopenic mice degraded antigen much more vigorously. In addition, microscopic analysis showed that degradation of OVA takes place in different cellular compartments in the cDC from RAG-deficient mice compared to WT cDC. Splenic cDC isolated from RAG -/-mice targeted OVA into lysosomes while in WT cDC antigen remained in early endosomes. It had previously been shown that early endosomes provide a milder environment for antigen degradation that enables DC to form MHC-peptide complexes [27] . In contrast, Mφ and other phagocytes target Ag into lysosomes where degradation is more efficient.
More rapid degradation of the antigen prevents formation of MHC-peptide complexes and blocks efficient T cell stimulation [28] .
FcγR had been shown to regulate the maturation of DC. Especially FcγRII was proposed to prevent spontaneous maturation of DC, thereby promoting steady state tolerance [13, 29] . Nevertheless, experiments employing splenic cDC isolated from different FcγR-deficient mice did not support the hypothesis that intravenous administration of Ig provides a FcγR-dependent signal to restore the impaired function of cDC from RAG-deficient mice. An FcR-independent mechanism of Ig function in this context was also suggested by our observation that IgM acted essentially identical to IgG. Recently, it was shown that expression of the Fc receptor for IgM, FcµR, is restricted to B cells and not expressed on T cells or DC [30] . Taken together, this report and our data strongly suggest that Ig acts independently of Fc receptors, FcγR or FcµR.
As our experiments essentially excluded Fc receptors and complement as effectors of Ig and also pointed towards mechanisms different from the uptake of IC and apoptotic cells, we explored whether CLR might mediate Ig-induced amelioration of cross-presentation. This was further prompted by our observation that CLR were upregulated on DC from RAG-deficient mice. Moreover, in a recent study Anthony et al demonstrated that anti-inflammatory activity of intravenous immunoglobulin (IVIG) is mediated by CLR, like DC-SIGN and SIGN-R1 [31, 32] . To test the hypothesis of a CLR-dependent effect we performed a bulk blockade of CLR by injection of mannan prior to administration of Ig. We observed that Ig were able to rescue efficient crosspresentation only when CLR were not blocked. Mannan is widely considered to be a specific inhibitor for CLR [20, 33, 34] . However, it cannot ultimately be excluded that an intervention using mannan might result in non-specific effects beyond inhibition of CLR. Thus, it has been proposed by others that mannan induced functional maturation of bone-marrow derived DC in vitro and of lymph node DC in vivo [35] .
However, these effects were evoked at much higher doses of mannan than those employed in our experiments. Of note, the reported effects of mannan on maturation of DC were dramatically lower in comparison to effects mediated by LPS and accordingly, we did not observe any phenotypic maturation of DC after administration of mannan at the concentration used throughout our study.
More than 20 CLR have been reported to be expressed on myeloid cells, which exhibit partially overlapping binding capacities for N-glycans and also engage similar downstream signaling pathways [18] . Thus, the CLR system is likely to be highly redundant also with respect to Ig binding. We detected elevated expression of the MR, SIGN-R1, SIGN-R2, and Clec9a on DC from RAG-deficient mice, raising the possibility that one or more of these or a different receptor at all might mediate Iginduced amelioration of cross-presentation. Analysis of Ig-binding to DC from MRdeficient mice did not reveal any difference in binding when compared to WT DC.
However, uptake of soluble OVA depends on MR, thereby precluding functional analysis of MR-deficiency in this experimental system [6] .
In summary, our studies excluding FcR-dependent and complement-dependent mechanisms as well as mechanisms mediating the uptake of IC or apoptotic cells in addition to our findings that the Ig-induced capacity to cross-present can be inhibited by the bona fide CLR-specific inhibitor mannan, leads us to suggest that interaction of soluble Ig with CLR is required to endow splenic DC with an antigen-processing machinery optimized for cross-presentation. 
Materials and Methods

Mice
Mouse lines used in this study were C57BL/6 (WT), OT I, RAG1 
Analysis of antigen presentation
For the experiments using soluble OVA or peptides, cDC were plated in 96-well plates (Nunc) at 1x10 
